Digital Mammography: Faculty

>Click Here to Preview Digital Mammography Online Now

>NEW! Apple® iPAD®* Version Click Here to Preview

This program is supported by the dedication and expertise of our USF College of Medicine faculty members, and distinguished Guest Faculty:

Claudia G. Berman, MD
Program Chairman / Professor of Radiology
USF College of Medicine
H. Lee Moffitt Cancer Center & Research Institute

Distinguished Guest Faculty:

Rachel F. Brem, MD
Director, Breast Imaging and Intervention
The George Washington University
Washington, DC

Maria Kallergi, Ph.D.
Associate Professor
Technical Educational Institute of Athens
Foundation for Biomedical Research of the Academy of Athens

Jerry A. Thomas, M.S., FAAPM, DABR, CHP, DABSNM
Radiological Physicist
Via Christi Regional Medical Center
Wichita, Kansas

Disclosure of Significant Relationships with Relevant Commercial Companies/Organizations

Disclosure of Relevant Financial Relationships
with Commercial Interests

USF Health endorses the standards of the ACCME, ANCC, and ACPE that requires everyone in a position to control the content of a CME/CE activity to disclose all financial relationships with commercial interests that are related to the content of the CME/CE activity. CME/CE activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

A conflict of interest is created when individuals in a position to control the content of CME/CE have a relevant financial relationship with a commercial interest which, therefore, may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.

USF Health will identify, review and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. USF Health does not endorse any products or services.

Relevant financial relationships exist between the following individuals and commercial interests:

Speaker Relationship CompanyStatus
John Doe, DO Consultant Biogen Idec Terminated
Mary Doe, MD Speaker’s BureauPfizer, Merck Active
Jane Doe, RN Nothing to Disclose
Planning Committee, USF Health OCPD staff members and the peer/content reviewer for this activity have no relevant financial relationships to disclose.
Disclosures are on file at the University of South Florida, Office of Continuing Professional Development.

The University of South Florida College of Medicine endorses the Standards of the Accreditation Council for Continuing Medical Education and the Guidelines of the Association of American Medical Colleges that the sponsors of continuing medical education activities and the speakers at these activities disclose significant relationships with commercial companies whose products or services are discussed in educational presentations. For sponsors, significant relationships include research grants, institutional agreements for joint initiatives, substantial gifts, or other relationships that benefit the institution. For speakers, significant relationships include receiving from a commercial company research grants, consultancies, honoraria and travel, or having a self-managed equity interest in a company.

Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Significant relationships exist between course faculty and the following companies/organizations whose products or services will be discussed during this CME activity:

Speaker,  Relationship ,Company
Sadie Augila, MD, None
John Beauchamp, MD, None
Claudia G. Berman, MD, None
Rachel F. Brem, MD Grants/Research Support Dilon Technologies, and Consultant Dilon Technologies; CAD Sciences, Consultant, Suros, Grants/ Research Support, Bristol-Myers Squibb; Stock Shareholder (self-managed) Dilon, CAD Sciences
Robert A, Clark, MD, None
Jody Cressman, MD, None
*Steven Harms, MD Grant/Research Support: Advanced Magnetics, Consultant: Advanced Magnetics, Bard, Ethicon, SenoRx . Stock/Shareholder: Aurora Imaging Technology. Honorarium: Berlex. Employee: Aurora Imaging Technology
Maria Kallergi, PhD None

Kevin M Kelly, MD, Stock Shareholder CEO, Sonocine, Inc.

Kamy R. Kemp, MD, Speakers Bureau, Oncotype Dx (Genomic Health)
Elsie Levin MD, Consultant, Aurora Imaging

Andreas Muehler MD MBA, Salary/Contractual Services (President), CAD Sciences

Pat Romilly, MD None

Matthew J. Saady, Grants/ Research Support, Naviscan (Clinical Trial)
Julian Safir, MD None
Margaret Szabunio, MD None
Jetty Thomas, MS, DABE, Speakers Bureau, Medical Tech Mgmt Institute; Stock/ Shareholder Self Managed, General Electric
Vesna Rachel, MD None
Irving Weinberg, MD, PhD Employee: NaviScan Pet Systems, Inc.

OFF-LABEL USAGE:
*Dr. Harms has indicated that he will discuss the off-label use of Combidex for lymph node imaging.
*Dr. Kallergi has indicated that she will discuss the off-label use of new systems for breast imaging currently used for research only, and the off label use of Digital Mammography Systems.

Dr. Kevin Kelly has disclosed that he will be discussing the off-label use of the Sonocine system of semi automated screening and whole breast ultrasound.

Breast Imaging Update >
Interactive Mammography Practice Based Education >
Digital  Mammography >
Breast MRI >
Breast Ultrasound >
Course Fees & Ordering Information>